Breathe Technologies (Fremont, CA) developer of medical devices for the treatment of chronic obstructive pulmonary disease, closed a $15M Series B financing. Participants include Kleiner Perkins Caufield & Byers, Synergy Partners International, Delphi Ventures and Life Science Angels.